Document is current

Any future updates will be listed below

High prognostic value of minimal residual disease detected by flow-cytometry-enhanced fluorescence in situ hybridization in core-binding factor acute myeloid leukemia (CBF-AML)

Crossref DOI link: https://doi.org/10.1007/s00277-014-2107-z

Published Online: 2014-05-21

Published Print: 2014-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark